✦ LIBER ✦

Neoadjuvant hormonal therapy is associated with a low risk of prostate specific antigen (PSA) recurrence in prostate cancer,

Book ID: 120869436
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2000
Weight: 151 KB
Volume: 1256
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200012560-00042

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prostate-specific antigen recurrence and

Prostate-specific antigen recurrence and mortality after conventional dose radiation therapy in select men with low-risk prostate cancer

✍ Joshua H. Petit; Ming-Hui Chen; Marian Loffredo; Brenda Sussman; Andrew A. Rensh 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB 👁 1 views

Circulating prostate-specific antigen mR

Circulating prostate-specific antigen mRNA during radical prostatectomy in patients with localized prostate cancer: with special reference to neoadjuvant hormonal therapy

✍ Ogawa, Osamu ;Iinuma, Masanori ;Sato, Kazunari ;Sasaki, Ryusei ;Shimoda, Naotake 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 186 KB

Prostate-specific antigen doubling time

Prostate-specific antigen doubling time is associated with survival in men with hormone-refractory prostate cancer

✍ Ross C. Semeniuk; Peter M. Venner; Scott North 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 133 KB

Favourable psa outcome in patients with

Favourable psa outcome in patients with large prostates or moderate risk prostate cancer treated by a combination brachytherapy and neoadjuvant hormonal therapy

✍ N. Stone; R. Stock; S. Hong 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 352 KB

Initial decline in hemoglobin during neo

Initial decline in hemoglobin during neoadjuvant hormonal therapy predicts for early prostate specific antigen failure following radiation and hormonal therapy for patients with intermediate and high-risk prostate cancer

✍ Anthony V. D'Amico; Tara Saegaert; Ming-Hui Chen; Andrew A. Renshaw; Daniel Geor 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 1 views

## Abstract ## BACKGROUND Declines in serum hemoglobin (Hgb) levels occur from the use of androgen suppression therapy (AST) in the treatment of prostate cancer patients. We studied whether time to prostate specific antigen (PSA) failure following external beam radiation therapy (RT) and AST could

Elevated levels of prostate-specific ant

Elevated levels of prostate-specific antigen (PSA) in prostate cancer cells expressing mutant p53 is associated with tumor metastasis

✍ Sean Downing; Clare Bumak; Sheri Nixdorf; Kim Ow; Pamela Russell; Paul Jackson 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 468 KB

## Abstract The underlying basis for rising levels of prostate‐specific antigen (PSA) in prostate cancer is not fully understood, but attention has turned to the possibility that loss of normal p53 function might be directly involved. We have investigated the relationship between p53 function and P